leukemia
FDA gives Orphan Drug Designation to Faron Pharmaceuticals’ Bexmarilimab
August 29, 2023Research and Development FDA, Faron, ODD, Oncology, leukemia
Faron Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its …
Kite’s leukaemia cell therapy application validated by EMA
June 24, 2021EMA, Kite, leukemia
Kite has announced that their Type II variation application for a new indication to the approved license for autologous anti-CD19-transduced …
MHRA approves venetoclax as acute myeloid leukemia treatment
June 8, 2021Manufacturing and Production EC, EU, MHRA, leukemia
The MHRA has announced its approval for AbbVie’s venetoclax, in combination with a hypomethylating agent, for the treatment of newly …
Pfizer’s Bosulif scores US green light in leukaemia sub-type
December 21, 2017Sales and Marketing FDA, Pfizer, bosulif, leukaemia, leukemia, pharma
Pfizer has revealed that its tyrosine kinase inhibitor Bosulif (bosutinib) has been awarded marketing authorisation from the FDA in the …
Ariad expands in Europe
February 22, 2013Sales and Marketing Ariad, leukaemia, leukemia
The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
